Greene R M, Linask K K, Pisano M M, Lloyd M R
Daniel Baugh Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.
J Craniofac Genet Dev Biol. 1989;9(2):207-22.
Certain hormonal primary messengers identified in the mammalian palate during its ontogeny transmit information to the interior of the cell via transmembrane signaling systems that control the production of the secondary messenger cyclic adenosine monophosphate. The singular role of intracellular cyclic AMP is to activate cAMP-dependent protein kinases (cAMP-dPK). cAMP-dPK were thus identified and characterized in the developing murine embryonic palate. Incubation of cytosolic fractions of embryonic palatal tissue with cAMP resulted in a dose-dependent increase in the cAMP-dPK activity ratio. A transient elevation of basal cAMP-dPK was seen during the period of palatal ontogeny that corresponded temporally with a previously demonstrated transient elevation of palatal basal cAMP levels. Fractions of embryonic palatal tissue cytosols derived by diethylaminoethyl (DEAE)-Sephacel chromatography were analyzed for phosphotransferase activity and for [3H]-cAMP binding to the regulatory (R) subunits of cAMP-dPK. Such analyses revealed two peaks of activity on day 13 of gestation. Based on the salt concentration at which the material in these peaks eluted from DEAE, its ability to cochromatograph with authentic cAMP-dPK isozymes, its molecular weight as determined by sodium dodecyl sulfate-polycrylamide gel electrophoresis, and the ability of the material to be photoaffinity labeled with [3H]-8-azidoadenosine 3',5' cyclic phosphate, types I and II cAMP-dPK were identified. Regulatory subunits of cAMP-dPK were characterized by the binding of [3H]-cAMP to cytosolic fractions of embryonic palatal tissue. Such binding was saturable (Bmax = 1,096 fmol/mg protein) and of high affinity (Kd = 7 nM). Only cAMP and cyclic guanosine monophosphate competed in a dose-related manner with [3H]-cAMP for binding to R subunits of cAMP-dPK. Adenosine, cTMP, and adenosine triphosphate, at doses up to 10(-4) M, did not compete for binding. Temporal analysis of binding data indicated that the number of binding sites transiently decreased during day 13 of gestation. Characterization of cAMP-dPK in tissue derived from the developing mammalian palate allows consideration of cAMP-dPK as a key regulatory enzyme capable of transducing hormonally elevated intracellular levels of cAMP into metabolic responses during orofacial ontogenesis.
在哺乳动物腭部个体发育过程中鉴定出的某些激素初级信使,通过跨膜信号系统将信息传递到细胞内部,该系统控制着次级信使环磷酸腺苷(cAMP)的产生。细胞内cAMP的独特作用是激活cAMP依赖性蛋白激酶(cAMP-dPK)。因此,在发育中的小鼠胚胎腭部鉴定并表征了cAMP-dPK。用cAMP孵育胚胎腭组织的胞质部分,导致cAMP-dPK活性比呈剂量依赖性增加。在腭部个体发育期间观察到基础cAMP-dPK的短暂升高,这在时间上与先前证明的腭部基础cAMP水平的短暂升高相对应。对通过二乙氨基乙基(DEAE)-Sephacel色谱法获得的胚胎腭组织胞质溶胶部分进行磷酸转移酶活性分析以及[3H]-cAMP与cAMP-dPK调节(R)亚基结合的分析。此类分析在妊娠第13天揭示了两个活性峰。根据这些峰中的物质从DEAE洗脱时的盐浓度、其与真实cAMP-dPK同工酶共色谱的能力、通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳测定的分子量以及该物质被[3H]-8-叠氮腺苷3',5'-环磷酸光亲和标记的能力,鉴定出了I型和II型cAMP-dPK。通过[3H]-cAMP与胚胎腭组织胞质部分的结合来表征cAMP-dPK的调节亚基。这种结合是可饱和的(Bmax = 1,096 fmol/mg蛋白质)且具有高亲和力(Kd = 7 nM)。只有cAMP和环磷酸鸟苷以剂量相关的方式与[3H]-cAMP竞争与cAMP-dPK的R亚基结合。腺苷、cTMP和三磷酸腺苷在高达10^(-4) M的剂量下不竞争结合。结合数据的时间分析表明,结合位点的数量在妊娠第13天短暂减少。对发育中的哺乳动物腭部组织中cAMP-dPK的表征使得能够将cAMP-dPK视为一种关键调节酶,它能够在口面部个体发育过程中将激素升高的细胞内cAMP水平转化为代谢反应。